Nurix Therapeutics NRIX Insider Ownership

NASDAQ NRIX
$25.66 +0.34 (+1.34%)
As of: Sep 4, 2026 · 11:43 AM EDT

Insider Holdings by Owner

183.37K Shares

Insider Ownership Statistics

as of 30 Sep, 2026
Insider Ownership
0.193%
-0.0042% pp QoQ
Shares Held by Insiders
183.37K
filed for Sep 2026
-2.14% QoQ
Shares Outstanding
95.06Mn
95,059,221 shares
Direct Holdings
183.37K
Indirect: 0
Net Shares Traded (QoQ)
-4.00K
net selling in Sep 2026
Insiders Holding Shares
5
with Form 4 holdings on file

Shares Owned by Insiders

Shares held % of outstanding
Latest
Average ownership
Peak ownership

Shares Purchased/Sold by Insiders

Bought Sold
Latest quarter
Net over range
Buying quarters

Insider Ownership Summary

Quarter ending 30 Sep, 2026

As of August 29, 2026, the three largest insider holders of NRIX are Gwenn Hansen (Chief Scientific Officer, 117.23K shares), Houte Hans Van (Chief Financial Officer, 40.17K shares), Julia P Gregory (Director, 10.75K shares).

Form 4 Holdings

Insiders Holding NRIX

Insiders 5
Shares held 183.37K
Of outstanding 0.193%
# Insider Position Direct Indirect Total Share of Insiders Last Filed
1 Gwenn Hansen Chief Scientific Officer 117,227 0 117,227 63.9% 01 Sep, 2026
2 Houte Hans Van Chief Financial Officer 40,166 0 40,166 21.9% 04 Aug, 2026
3 Julia P Gregory Director 10,750 0 10,750 5.9% 17 Sep, 2025
4 Christine Ring Chief Legal Officer 9,110 0 9,110 5.0% 03 Aug, 2026
5 Stefani Wolff Evp And Coo 6,113 0 6,113 3.3% 02 May, 2023

Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.

Form 4 Filings

1,001 Insider Transactions

Source SEC Form 4
Latest quarter Sep 2026
Download Data
Date Insider Position Transaction Shares Price Value Shares Held After Ownership
01 Sep, 2026 Gwenn Hansen Chief Scientific Officer Acquired M 1,452 $1.86 $2.70K 118,679 Direct
01 Sep, 2026 Gwenn Hansen Chief Scientific Officer Disposed S 1,452 $25.47 $36.98K 117,227 Direct
01 Sep, 2026 Gwenn Hansen Chief Scientific Officer Disposed M 1,452 $0.00 $0 60,858 Direct
05 Aug, 2026 Gwenn Hansen Chief Scientific Officer Acquired M 4,356 $1.86 $8.10K 121,583 Direct
04 Aug, 2026 Gwenn Hansen Chief Scientific Officer Disposed S 1,500 $23.87 $35.80K 119,838 Direct
04 Aug, 2026 Gwenn Hansen Chief Scientific Officer Disposed S 2,611 $24.64 $64.34K 117,227 Direct
05 Aug, 2026 Gwenn Hansen Chief Scientific Officer Disposed S 4,356 $25.00 $108.90K 117,227 Direct
05 Aug, 2026 Gwenn Hansen Chief Scientific Officer Disposed M 4,356 $0.00 $0 62,310 Direct
04 Aug, 2026 Houte Hans Van Chief Financial Officer Disposed S 1,794 $23.89 $42.86K 43,133 Direct
04 Aug, 2026 Houte Hans Van Chief Financial Officer Disposed S 2,967 $24.65 $73.13K 40,166 Direct
03 Aug, 2026 Christine Ring Chief Legal Officer Acquired M 5,787 $8.72 $50.46K 25,699 Direct
03 Aug, 2026 Christine Ring Chief Legal Officer Disposed S 16,589 $23.05 $382.36K 9,110 Direct
03 Aug, 2026 Christine Ring Chief Legal Officer Disposed M 5,787 $0.00 $0 122,824 Direct
30 Jul, 2026 Houte Hans Van Chief Financial Officer Acquired M 3,750 $0.00 $0 41,342 Direct
30 Jul, 2026 Christine Ring Chief Legal Officer Acquired M 3,750 $0.00 $0 17,329 Direct
30 Jul, 2026 Gwenn Hansen Chief Scientific Officer Acquired M 3,750 $0.00 $0 118,755 Direct
30 Jul, 2026 Houte Hans Van Chief Financial Officer Acquired M 2,858 $0.00 $0 44,200 Direct
30 Jul, 2026 Gwenn Hansen Chief Scientific Officer Acquired M 2,858 $0.00 $0 121,613 Direct
30 Jul, 2026 Christine Ring Chief Legal Officer Acquired M 2,858 $0.00 $0 20,187 Direct
30 Jul, 2026 Gwenn Hansen Chief Scientific Officer Acquired M 3,572 $0.00 $0 125,185 Direct